|
1
|
Maitra A and Hruban RH: Pancreatic cancer.
Annu Rev Pathol. 3:157–188. 2008. View Article : Google Scholar
|
|
2
|
Niederhuber JE, Brennan MF and Menck HR:
The National Cancer Data Base report on pancreatic cancer. Cancer.
76:1671–1677. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen Y, Sun XJ, Jiang TH and Mao AW:
Combined radiochemotherapy in patients with locally advanced
pancreatic cancer: a meta-analysis. World J Gastroenterol.
19:7461–7471. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Folkman MJ, Long DM Jr and Becker FF:
Growth and metastasis of tumor in organ culture. Cancer.
16:453–467. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Holmgren L, O’Reilly MS and Folkman J:
Dormancy of micrometastases: balanced proliferation and apoptosis
in the presence of angiogenesis suppression. Nat Med. 1:149–153.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parangi S, O’Reilly M, Christofori G,
Holmgren L, Grosfeld J, Folkman J and Hanahan D: Antiangiogenic
therapy of transgenic mice impairs de novo tumor growth. Proc Natl
Acad Sci USA. 93:2002–2007. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Djuranovic S, Nahvi A and Green R: A
parsimonious model for gene regulation by miRNAs. Science.
331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Otsuka M, Zheng M, Hayashi M, Lee JD,
Yoshino O, Lin S and Han J: Impaired microRNA processing causes
corpus luteum insufficiency and infertility in mice. J Clin Invest.
118:1944–1954. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang WJ, Yang DD, Na S, Sandusky GE, Zhang
Q and Zhao G: Dicer is required for embryonic angiogenesis during
mouse development. J Biol Chem. 280:9330–9335. 2005. View Article : Google Scholar
|
|
11
|
Kuehbacher A, Urbich C, Zeiher AM and
Dimmeler S: Role of Dicer and Drosha for endothelial microRNA
expression and angiogenesis. Circ Res. 101:59–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang S and Olson EN: AngiomiRs – key
regulators of angiogenesis. Curr Opin Genet Dev. 19:205–211. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Würdinger T, Tannous BA, Saydam O, Skog J,
Grau S, Soutschek J, Weissleder R, Breakefield XO and Krichevsky
AM: miR-296 regulates growth factor receptor overexpression in
angiogenic endothelial cells. Cancer Cell. 14:382–393. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng Y, Li S, Ding Y, Wang Q, Luo H, Shi
Q, Hao Z, Xiao G and Tong S: The role of miR-18a in gastric cancer
angiogenesis. Hepatogastroenterology. 60:1809–1813. 2013.
|
|
15
|
Poliseno L, Tuccoli A, Mariani L,
Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S and
Rainaldi G: MicroRNAs modulate the angiogenic properties of HUVECs.
Blood. 108:3068–3071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li YX, Liu DQ, Zheng C, Zheng SQ, Liu M,
Li X and Tang H: miR-200a modulate HUVEC viability and migration.
IUBMB Life. 63:553–559. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raimondi L, Amodio N, Di Martino MT,
Altomare E, Leotta M, Caracciolo D, Gullà A, Neri A, Taverna S,
D’Aquila P, et al: Targeting of multiple myeloma-related
angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor
activity. Oncotarget. 5:3039–3054. 2014.PubMed/NCBI
|
|
18
|
Chamorro-Jorganes A, Araldi E, Rotllan N,
Cirera-Salinas D and Suárez Y: Autoregulation of glypican-1 by
intronic microRNA-149 fine tunes the angiogenic response to FGF2 in
human endothelial cells. J Cell Sci. 127:1169–1178. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naschberger E, Schellerer VS, Rau TT,
Croner RS and Stürzl M: Isolation of endothelial cells from human
tumors. Methods Mol Biol. 731:209–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Mil A, Vrijsen KR, Goumans MJ, Metz
CH, Doevendans PA and Sluijter JP: MicroRNA-1 enhances the
angiogenic differentiation of human cardiomyocyte progenitor cells.
J Mol Med. 91:1001–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chim SM, Qin A, Tickner J, Pavlos N, Davey
T, Wang H, Guo Y, Zheng MH and Xu J: EGFL6 promotes endothelial
cell migration and angiogenesis through the activation of
extracellular signal-regulated kinase. J Biol Chem.
286:22035–22046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Amodeo V, Bazan V, Fanale D, Insalaco L,
Caruso S, Cicero G, Bronte G, Rolfo C, Santini D and Russo A:
Effects of anti-miR-182 on TSP-1 expression in human colon cancer
cells: there is a sense in antisense? Expert Opin Ther Targets.
17:1249–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Donnem T, Fenton CG, Lonvik K, Berg T,
Eklo K, Andersen S, Stenvold H, Al-Shibli K, Al-Saad S, Bremnes RM,
et al: MicroRNA signatures in tumor tissue related to angiogenesis
in non-small cell lung cancer. PLoS One. 7:e296712012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Geng L, Chaudhuri A, Talmon G, Wisecarver
JL, Are C, Brattain M and Wang J: MicroRNA-192 suppresses liver
metastasis of colon cancer. Oncogene. 33:5332–5340. 2014.
View Article : Google Scholar :
|
|
25
|
Sundaram P, Hultine S, Smith LM, Dews M,
Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, et
al: p53-responsive miR-194 inhibits thrombospondin-1 and promotes
angiogenesis in colon cancers. Cancer Res. 71:7490–7501. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pecot CV, Rupaimoole R, Yang D, Akbani R,
Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, et al:
Tumour angiogenesis regulation by the miR-200 family. Nat Commun.
4:24272013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu X, Er K, Mao C, Yan Q, Xu H, Zhang Y,
Zhu J, Cui F, Zhao W and Shi H: miR-203 suppresses tumor growth and
angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol
Biochem. 32:64–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang W, Yu F, Yao H, Cui X, Jiao Y, Lin L,
Chen J, Yin D, Song E and Liu Q: miR-27a regulates endothelial
differentiation of breast cancer stem like cells. Oncogene.
33:2629–2638. 2014. View Article : Google Scholar
|
|
29
|
Urbich C, Kaluza D, Frömel T, Knau A,
Bennewitz K, Boon RA, Bonauer A, Doebele C, Boeckel JN,
Hergenreider E, et al: MicroRNA-27a/b controls endothelial cell
repulsion and angiogenesis by targeting semaphorin 6A. Blood.
119:1607–1616. 2012. View Article : Google Scholar
|
|
30
|
Reddi HV, Driscoll CB, Madde P, Milosevic
D, Hurley RM, McDonough SJ, Hallanger-Johnson J, McIver B and
Eberhardt NL: Redifferentiation and induction of tumor suppressors
miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits
anaplastic thyroid cancer: a novel therapeutic strategy. Cancer
Gene Ther. 20:267–275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ando H, Okamoto A, Yokota M, Shimizu K,
Asai T, Dewa T and Oku N: Development of a miR-92a delivery system
for anti-angiogenesis-based cancer therapy. J Gene Med. 15:20–27.
2013. View
Article : Google Scholar
|
|
32
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo HN, Wang ZH, Sheng Y, Zhang Q, Yan J,
Hou J, Zhu K, Cheng Y, Xu YL, Zhang XH, et al: miR-139 targets
CXCR4 and inhibits the proliferation and metastasis of laryngeal
squamous carcinoma cells. Med Oncol. 31:7892014. View Article : Google Scholar
|
|
34
|
Skalsky RL and Cullen BR: Reduced
expression of brain-enriched microRNAs in glioblastomas permits
targeted regulation of a cell death gene. PLoS One. 6:e242482011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wong CC, Wong CM, Tung EK, Au SL, Lee JM,
Poon RT, Man K and Ng IO: The microRNA miR-139 suppresses
metastasis and progression of hepatocellular carcinoma by
down-regulating Rho-kinase 2. Gastroenterology. 140:322–331. 2011.
View Article : Google Scholar
|
|
36
|
Li RY, Chen LC, Zhang HY, Du WZ, Feng Y,
Wang HB, Wen JQ, Liu X, Li XF, Sun Y, et al: MiR-139 inhibits Mcl-1
expression and potentiates TMZ-induced apoptosis in glioma. CNS
Neurosci Ther. 19:477–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luo Z, Wen G, Wang G, Pu X, Ye S, Xu Q,
Wang W and Xiao Q: MicroRNA-200C and -150 play an important role in
endothelial cell differentiation and vasculogenesis by targeting
transcription repressor ZEB1. Stem Cells. 31:1749–1762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chuang TD, Panda H, Luo X and Chegini N:
miR-200c is aberrantly expressed in leiomyomas in an
ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.
Endocr Relat Cancer. 19:541–556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Snowdon J, Zhang X, Childs T, Tron VA and
Feilotter H: The microRNA-200 family is upregulated in endometrial
carcinoma. PLoS One. 6:e228282011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Panda H, Pelakh L, Chuang TD, Luo X,
Bukulmez O and Chegini N: Endometrial miR-200c is altered during
transformation into cancerous states and targets the expression of
ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5. Reprod Sci. 19:786–796.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Etienne W, Meyer MH, Peppers J and Meyer
RA Jr: Comparison of mRNA gene expression by RT-PCR and DNA
microarray. Biotechniques. 36:618–626. 2004.PubMed/NCBI
|
|
42
|
Beckman KB, Lee KY, Golden T and Melov S:
Gene expression profiling in mitochondrial disease: assessment of
microarray accuracy by high-throughput Q-PCR. Mitochondrion.
4:453–470. 2004. View Article : Google Scholar
|
|
43
|
Morey JS, Ryan JC and Van Dolah FM:
Microarray validation: factors influencing correlation between
oligonucleotide microarrays and real-time PCR. Biol Proced Online.
8:175–193. 2006. View
Article : Google Scholar
|
|
44
|
Lin CY, Lee HC, Fu CY, Ding YY, Chen JS,
Lee MH, Huang WJ and Tsai HJ: miR-1 and miR-206 target different
genes to have opposing roles during angiogenesis in zebrafish
embryos. Nat Commun. 4:28292013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Davalos V and Esteller M: Opening the
treasure chest of miR-200s family members. Cell Cycle. 8:2141–2142.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Brabletz S and Brabletz T: The ZEB/miR-200
feedback loop -a motor of cellular plasticity in development and
cancer? EMBO Rep. 11:670–677. 2010. View Article : Google Scholar : PubMed/NCBI
|
